UK markets closed

Celyad Oncology SA (0QFK.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.3680-0.0010 (-0.27%)
At close: 03:50PM GMT
Full screen
Loading interactive chart…
  • GlobeNewswire

    Celyad Oncology announces intention to terminate SEC reporting obligations

    MONT-SAINT-GUIBERT, Belgium, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) announces that it will voluntarily file a Form 15F with the United States Securities and Exchange Commission (the “SEC”) to terminate its SEC reporting obligations under Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Upon filing of the Form 15F, the Company’s SEC reporting obligations will be immediately s

  • GlobeNewswire

    Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

    Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin ribonucleic acid (shRNAs)-derived sequences to broaden the capacities of CAR-TsDifferentiated targets to widen the range of indications and the development of multispecific CARs to overcome the main limitations of current CAR-T therapiesA robust and broad Intellectual Property (IP) portfolio MONT-SAINT-

  • GlobeNewswire

    Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

    MONT-SAINT-GUIBERT, Belgium, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a notification of transparency dated December 19, 2023, indicating that CFIP CLYD (UK) Limited, an affiliate of Fortre